Top
Bluestem
  • Who We Are
  • Strategy
  • Portfolio
  • Newsroom
  • INVESTOR PORTAL 2025
Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • INVESTOR PORTAL 2025/
iStock-645678506 dark.png
Bluestem

Newsroom

Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • INVESTOR PORTAL 2025/

News From the Bluestem Team


April 29, 2019

eyeBrain in the News

April 29, 2019/ Michele Kleinwolterink

eyeBrain’s Neurolens is included in this story about companies focused on disrupting the eyewear market.. Click here to read the story or see a PDF version here.

-Shared by Steve Kirby, board member of eyeBrain Medical Inc.

April 29, 2019/ Michele Kleinwolterink/

Michele Kleinwolterink

  • Transcript of OCTANe Q&A with ...
  • Ambient Clinical Analytics - ...

*Legal Disclaimer: NEWSROOM The content provided herein is for informational and convenience purposes only. The information provided on this website does not constitute an offer to buy or sell any securities or provide any form of investment advice.  Bluestem Capital Company, LLC assumes no responsibility nor makes any claims as to the quality, accuracy or usefulness of third-party linked content made available on this site.

Bluestem is the registered service mark of Bluestem Capital Company, LLC. All Rights Reserved.